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High blood pressure (BP) is responsible for a large and 
increasing proportion of the burden of disease. Its impact is 
now recognised as global, and it is one of the leading causes 
of disease in middle-income countries and of emerging 
importance in low-income countries. Globally, analyses 
indicate that about two-thirds of strokes and almost half of all 
ischaemic heart disease (IHD) cases are attributable to raised 
BP (systolic BP ≥ (SBP) 115 mmHg).1 
It has also become increasingly evident that the association 
between BP and stroke, IHD and renal failure is direct and 
continuous from relatively low levels. 2-4  In fact, the majority 
of disease associated with BP and other continuous risk 
factors, such as cholesterol level and body weight, occurs in 
people with suboptimal levels below the thresholds set for 
hypertension, hypercholesterolaemia or obesity. 
The 1998 South African Demographic and Health Survey 
(SADHS)5  provided nationally representative data on 
hypertension. The mean SBP for those over the age of 15 
years was 123 mmHg for men and 119 mmHg for women.6  
The prevalence of hypertension (BP greater than 140 mmHg 
systolic and/or 90 mmHg diastolic using the current World 
Health Organization (WHO) cut-off) was 21%, and 25% 
when age-standardised to the world population.6 The degree 
of urbanisation among black Africans predisposes to the 
development of hypertension,7  suggesting that it may increase 
with continued trends towards urbanisation. Using the former 
WHO cut-off of 160/95 mmHg, the SADHS also showed that 
26% of hypertensive men and 38% of hypertensive women 
had their BP controlled indicating considerable underdiagnosis 
and treatment.5 Further analysis revealed that the poorer, 
younger men, without health insurance had the worst level of 
hypertension control.8 
This article uses existing SADHS data on prevalence in 
adults aged 30 years and older to quantify adverse health 
consequences associated with high BP, and to estimate the 
burden of disease attributed to high BP by sex and age group 
in South Africa for the year 2000.
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Objectives. To estimate the burden of disease attributable to 
high blood pressure (BP) in adults aged 30 years and older in 
South Africa in 2000.  
Design. World Health Organization comparative risk 
assessment (CRA) methodology was followed. Mean systolic 
BP (SBP) estimates by age and sex were obtained from the 1998 
South African Demographic and Health Survey adult data. 
Population-attributable fractions were calculated and applied 
to revised burden of disease estimates for the relevant disease 
categories for South Africa in 2000. Monte Carlo simulation-
modelling techniques were used for uncertainty analysis.
Setting. South Africa.
Subjects. Adults aged 30 years and older.
Outcome measures. Mortality and disability-adjusted life 
years (DALYs) from ischaemic heart disease (IHD), stroke, 
hypertensive disease and other cardiovascular disease (CVD).
Results. High BP was estimated to have caused 46 888 deaths 
(95% uncertainty interval 44 878 - 48 566) or 9% (95% uncertainty 
interval 8.6 - 9.3%) of all deaths in South Africa in 2000, and 
390 860 DALYs (95% uncertainty interval 377 955 - 402 256) 
or 2.4% of all DALYs (95% uncertainty interval 2.3 - 2.5%) in 
South Africa in 2000. Overall, 50% of stroke, 42% of IHD, 72% 
of hypertensive disease and 22% of other CVD burden in adult 
males and females (30+ years) were attributable to high BP 
(systolic BP ≥ 115 mmHg).
Conclusions. High BP contributes to a considerable burden 
of CVD in South Africa and results indicate that there is 
considerable potential for health gain from implementing 
BP-lowering interventions that are known to be highly cost-
effective. 
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Methods 
Using WHO comparative risk assessment (CRA) 
methodology,9,10 the disease burden attributable to a particular 
risk factor is estimated by comparing the current local health 
status with a theoretical minimum counterfactual with the 
lowest possible risk. The population-attributable fraction 
(PAF) of disease burden in a population is determined by the 
prevalence of exposure to the risk factor in the population, and 
the relative risk (RR) of disease occurrence given exposure. 
SBP in mmHg usually rises steadily with age. In contrast, 
diastolic BP (DBP) increases through the 4th or 5th decade, 
but then plateaus and begins to decline in the 6th and 7th 
decades, making SBP or pulse pressure (the difference between 
the two) better predictors for future adverse events than DBP. 
SBP was therefore chosen because data are widely available 
for this index of BP, and it appears to be a good predictor of 
cardiovascular disease (CVD).1 
The outcomes selected were those assessed in the WHO 
global CRA study by Lawes et al.1 based on consistent direct 
and continuous associations in cohort studies and evidence 
from randomised clinical trials, and included stroke, IHD, 
hypertensive disease and other CVD. Other CVD does 
not include heart failure, pulmonary oedema and cardiac 
arrhythmias since these conditions have been redistributed 
across specified cardiovascular outcomes in the South African 
National Burden of Disease Study.11 Data suggested causal 
relationships with renal failure, but since this could not be 
mapped to a burden of disease outcome, it was not included in 
the global study,1 or in this one.   
Estimates of mean SBP and standard deviations (SD) by 
age and sex for adults aged 30 years and older were obtained 
from a re-analysis of the 1998 SADHS data.5 BP was measured 
electronically in the 1998 SADHS, in part because initial 
training in the pilot study highlighted the need for a more 
automated process for fieldworkers with limited clinical skills 
to achieve accurate BP readings. BP measurements were taken 
after the participant had been seated for 5 minutes using an 
Omron M1 electronic BP manometer (Omron Life Science Co. 
Ltd, Tokyo Japan). BP and pulse were taken 3 times on the 
left arm with the palm upward.6 If the second measurement 
differed by more than 5 mmHg from the first, the first reading 
was excluded.6 Confidence intervals (CIs) around mean SBP 
estimates were calculated to reflect the sampling error. Use of 
the Omron electronic manometer rather than the auscultatory 
method using a mercury sphygmomanometer was motivated 
by the recommendation of international bodies and extensive 
validation testing of these instruments.6,12-14 
In the WHO global CRA study,1 data on risk factor-disease 
relationships were obtained from the Asia-Pacific Cohort 
Studies Collaboration (APCSC) data for 2001. In the present 
analysis, however, we used risk ratios obtained from a 
collaborative meta-analysis of individual participant data from 
61 separate prospective studies. In the Prospective Studies 
Collaboration,15  information was obtained on each of 1 million 
adults with no previous vascular disease, recorded at baseline 
in prospective observational studies of blood pressure and 
mortality. Hazard ratios in each decade of age associated with 
a 20 mmHg lower usual SBP at the start of that decade are 
presented in Table I for stroke, IHD, hypertensive disease and 
other CVD mortality together with ICD-9 codes.16 At ages 40 - 
69 years, each difference of 20 mmHg usual SBP was associated 
with more than a twofold difference in the death rate from 
stroke, and with twofold differences in death rates from IHD 
and other CVD.15 
There was attenuation of proportional associations with 
age for all outcomes, and these were about half as extreme at 
ages 80 - 89 as at ages 40 - 49.15 Age-specific associations were 
similar for men and women, and hence it was not necessary to 
have sex-specific estimates for CRA. Age-specific associations 
were also similar for cerebral haemorrhage and cerebral 
ischaemia, and hence all types of stroke were considered in this 
analysis.
Regression dilution bias has particular relevance in 
observational studies of BP.  This bias occurs since baseline or 
‘one-off’ measures of BP are subject to random fluctuations, 
due partly to the measurement process, and partly to real 
but temporary deviations from the ‘usual’ exposure level. 
Consequently, baseline exposure values have a wider 
distribution than the ‘usual’ exposure values, and with 
repeated measures there is a ‘regression to the mean’ of values 
whereby an initially extreme observation tends to become less 
abnormal with replication. This bias is accounted for in the 
estimates of RR,15,17 and needs also to be reflected in a narrower 
distribution around mean SBP levels. Hence this analysis 
involved correction for ‘time-dependent’ regression dilution,15 
and observed SDs around mean SBP levels in SADHS 1998 
data were corrected using the published correction dilution 
ratios.15 
Customised MS Excel spreadsheets based on templates used 
in the Clinical Trials Research Unit (CTRU) at the University of 
Auckland (S Vander Hoorn, University of Auckland – personal 
communication, 2005) as well as Australian studies (T Vos, 
University of Queensland – personal communication, 2005) 
were used to calculate the attributable burden using a discrete 
version of the general potential impact fraction (see below), 
taking into account continuous risk factor-disease exposures 
compared with a theoretical minimum distribution (conferring 
the lowest possible risk) on a categorical scale. 
1)1(
)1(
0
1
+−
−
=
∑
∑
=
=
k
i
ii
k
i
ii
Rp
Rp
PAFPAF
n
i=1
Pi RRi –
1)1(
)1(
0
+−
−∑
=
k
i
ii
k
i
ii
Rp
Rp
PA
i=1
n
Pi RRi
1)1(
)1(
0
+−
−
=
∑
∑
=
k
i
ii
k
i
ii
Rp
Rp
PAF
n
i=1
1)1(
)1(
0
+−
−
=
∑
∑
=
k
i
ii
k
i
ii
Rp
Rp
PAF
P'i RRi
high blood.indd   693 7/31/07   5:11:04 PM
August 2007, Vol. 97, No. 8  SAMJ
ORIGINAL ARTICLES
694
where n = the number of exposure 
categories; Pi = the proportion of 
population in exposure category i; 
RRi = the relative risk for exposure 
category i; and P'i = the proportion 
of population in exposure category i 
in the counterfactual distribution.
The theoretical minimum 
exposure distribution is zero in most 
cases, since zero exposure reﬂects 
minimum risk (e.g. no smoking). 
For high BP, however, zero exposure 
would be physiologically impossible, 
and therefore is an inappropriate 
choice as the theoretical minimum. 
The theoretical minimum of SBP 
was estimated to be a mean of 115 
mmHg and SD of 6 mmHg for all 
age and sex groups. This theoretical 
minimum is based on the SBP level 
down to which epidemiological 
relationships with cardiovascular 
outcomes are observed, and is also 
consistent with levels of SBP in 
populations with little or no CVD. 
Recent data from clinical trials have 
also indicated a reduction in stroke 
after lowering SBP by 10 mmHg in 
participants with a mean SBP of 125 
mmHg.1 
The PAFs were then applied to 
revised South African burden of 
disease estimates for 2000,18 deaths, 
years of life lost (YLLs), years of life 
lived with disability (YLDs) and 
disability-adjusted life years (DALYs) 
for the relevant disease categories to 
calculate attributable burden.  
Monte Carlo simulation-modelling 
techniques were used to present 
uncertainty ranges around point 
estimates that reflect all the main 
sources of uncertainty in the 
calculations. We used the @RISK 
software version 4.5 for Excel,19  
which allows multiple recalculations 
of a spreadsheet, each time choosing 
a value from distributions defined 
for input variables. Normal 
probability distributions were 
specified around the mean SBP 
by age and sex. For the RR input 
variables a normal distribution 
was specified, with the natural 
logarithm of the RR estimates as the 
entered means of the distribution 
and standard errors derived from 
the published 95% CIs (Table I). For 
each of the output variables (namely 
attributable burden as a percentage 
of total burden in South Africa in 
2000), 95% uncertainty intervals were 
calculated bounded by the 2.5th 
and 97.5th percentiles of the 2000 
iteration values generated.
Results 
Table II shows the mean SBP by age 
and sex and corrected SDs using age-
specific correction ratios. Mean SBP 
increased with age and was higher 
in men than in women across all 
ages, excepting the 70 - 79 and 80+ 
age groups in which mean SBP was 
higher in women than in men. 
The PAFs for high BP are shown 
for males and females by age 
group in Table III for all the related 
outcomes. PAFs were higher in 
men under the age of 70, and 
higher in women in the 70+ age 
group. Overall, about 42% of IHD 
burden in adults aged 30 years and 
older was attributable to SBP ≥ 115 
mmHg. PAFs for stroke were higher 
than for IHD for both males and 
females. Fifty-one per cent of stroke 
in males and 48% in females was 
attributable to SBP ≥ 115 mmHg. In 
both males and females stroke PAFs 
peaked in the 60 - 69-year age group 
at above 60%, with a downward 
trend thereafter. A similar pattern 
is noticed for IHD, but with lower 
attributable fractions. About 24% 
and 20% of other CVD and 73% and 
71% of hypertensive disease was 
attributable to SBP ≥ 115 mmHg in 
males and females, respectively. 
High BP was estimated to cause 46 
888 deaths (95% uncertainty interval 
44 878 - 48 566), accounting for 9% 
(95% uncertainty interval 8.6 - 9.3%) 
of all deaths in South Africa in 2000 
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(Table IV). In total, there were more attributable deaths and 
DALYs in females than in males, and BP accounted for 11.2% of 
all female and 7.0% of all male deaths in South Africa in 2000. 
In males, IHD accounted for the most deaths, but the DALYs 
for stroke were higher than those for IHD because of the 
greater disability component for stroke. In women, both stroke 
deaths and DALYs were highest. Since most BP-related deaths 
and non-fatal events occur in middle age and in the elderly, the 
loss of healthy life years comprised a smaller proportion of the 
total: 390 860 DALYs (95% uncertainty interval 377 955 - 402 
256) or 2.4% of all DALYs (95% uncertainty interval 2.3 - 2.5%) 
in South Africa in 2000. 
Although the same age-specific hazard ratios were used 
for males and females for each outcome, when comparing 
the burden (or DALYs) attributable to high BP it is clear that 
there is a marked difference between males and females (Fig. 
1). In men, IHD and stroke account for similar proportions 
(about 38%) of the total attributable burden, but in women 
stroke accounts for the highest proportion (43.0%), followed 
by hypertensive disease (30.2%), with IHD accounting for only 
23.6% of the burden attributable to high BP (Fig. 1).  
There are more attributable deaths in males in the younger 
age groups, but in older persons (60+ years of age) there 
are more female than male-attributable deaths. For males, 
attributable deaths peaked at 70 - 79 years, with a decline in 
the 80+ age group. For females the peak is in the 80+ age group 
(Fig. 2). 
Discussion 
This study estimates that in the year 2000, almost 47 000 
deaths in South Africa were attributed to high BP, accounting 
for about 9% of all deaths and contributing to 2.4% of total 
DALYs. Worldwide, high BP is estimated to cause 7.1 million 
deaths (12.8% of total) and 64.3 million DALYs (4.4% of the 
total burden).1 In South Africa, high BP was the second leading 
risk factor in terms of deaths, following sexually transmitted 
diseases resulting from unsafe sex, which accounted for 26.3% 
of all deaths in South Africa in 2000. If the sexually transmitted 
diseases such as HIV/AIDS, which strike people while they are 
much younger, were reduced, it is likely that the proportion of 
South African deaths related to high BP would be closer to the 
worldwide estimates. 
Table III. High blood pressure population-attributable fractions (%) for selected health outcomes by age and sex, South Africa, 
2000 
        
        Age (yrs)
Health outcome   30 - 44  45 - 59  60 - 69  70 - 79              80+  30+
Males      
Ischaemic heart disease    23.3    41.6    51.7    48.3             37.9 41.9
Stroke      32.5    53.8    63.8    59.5             37.9 51.3
Hypertensive disease    49.1    74.7    85.3    84.6             76.3 72.7
Other cardiovascular diseases   15.8    26.3    35.9    27.9             20.9 24.1
Females          
Ischaemic heart disease    11.7    37.5    50.3    49.3             44.0 41.5
Stroke      17.0    49.2    62.3    60.7             44.0 48.4
Hypertensive disease    28.2    70.4    84.3    85.8             82.9 70.9
Other cardiovascular diseases      7.5    23.1    34.6    28.7             25.2 19.5
Persons      
Ischaemic heart disease    19.8    40.1    51.1    48.8             42.0 41.7
Stroke      24.6    51.2    62.9    60.3             42.3 49.6
Hypertensive disease    36.8    72.2    84.6    85.5             81.4 71.5
Other cardiovascular diseases   11.2    24.7    35.2    28.4             23.6 21.6
Table II. Estimates of age-specific mean systolic blood pressure (SBP) and standard deviations (SDs) (mmHg) for males and 
females in South Africa, 2000, and regression dilution ratios by age
               Age (yrs)
Parameter   30 - 44  45 - 59  60 - 69  70 - 79  80+
Males     
Mean SBP      122     130     138     140  139
SD*         11       13       14       13    11
Females        
Mean SBP      116     128     137      141  144
SD*         13       13       14       14    13
Regression/dilution ratio    0.67    0.62     0.58     0.54                 0.49
*Corrected by regression/dilution ratio from the Prospective Studies Collaboration.15
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estimates for the sub-Saharan African region, which show the 
overall burden of CVD deaths to be roughly split between 
stroke and IHD.20  Furthermore, our results show interesting 
gender differences. High BP results in similar numbers 
of deaths and DALYs from stroke and IHD in men, but 
substantially higher burden from stroke compared with IHD 
among women. This would suggest that South African men 
may be further into the cardiovascular transition than women.
It is important to note that the hazard ratios15 used in this 
study are different from those used in the global study.1 The 
RRs used in this analysis, obtained from the Prospective 
Studies Collaboration,15 are robust and reflect the best available 
evidence given the best available data and methods of analysis 
to hand (S Vander Hoorn, University of Auckland – personal 
communication, 2005).  We have used the results from this 
meta-analysis since the evidence is based on a larger number of 
CVD events. The RRs used in these calculations are consistent 
with those used at the University of Auckland as well as in 
Australian CRA studies, and although there are some minor 
deviations in the RRs used from those reported in the WHO 
CRA chapter,1 they do not differ substantially. Results obtained 
under the various possible RRs available for CVD do not vary 
greatly (data not shown).
A variety of population-based and personal interventions 
have been shown to be effective to reduce risk associated 
with suboptimal BP. Successful public health interventions 
combine multiple activities, resulting in synergistic effects to 
reduce the overall BP levels in the population as a whole. They 
require clear co-ordination, multiple messages from various 
organisations, and support from the food industry to reduce 
Table IV. Burden attributable to high blood pressure in males and females, South Africa, 2000
                        Males                      Females                     Persons
Health outcome             Deaths                DALYs             Deaths                 DALYs               Deaths                DALYs
Ischaemic heart disease                7 733                  68 376                7 456                  49 625               15 189                118 001
Stroke                6 898                  69 481              10 426                  90 395               17 324                159 876
Hypertensive disease                3 951                  35 489                8 973                  63 449               12 924                  98 938
Other cardiovascular diseases                   686                    7 243                   765                    6 802                 1 451                  14 045
Total              19 268                180 589              27 620                210 271               46 888                390 860
95% uncertainty interval 18 127 - 20 260 172 409 - 188 249 26 093 - 28 865 201 525 - 217 654 44 878 - 48 566 377 955 - 402 256
% of total burden                 7.0%                      2.1%               11.2%                     2.7%                  9.0%                    2.4%
95% uncertainty interval         6.6 - 7.4%             2.0 - 2.2%     10.6 - 11.7%             2.6 - 2.8%          8.6 - 9.3%            2.3 - 2.5%
DALYs = disability-adjusted life years.
Fig. 1. Burden attributable to high blood pressure in males and females, 
South Africa, 2000.
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Fig. 2. Deaths attributable to high blood pressure for males and females by 
age group, South Africa, 2000.
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the salt content of staple foods in the country and to label 
food accordingly. Government action to reduce salt content 
of processed foods is a cost-effective way to limit CVD,21  and 
could reduce hypertension-related deaths. A recent randomised 
trial has demonstrated that modification of the salt content of 
a limited number of commonly consumed foods (that reduce 
the amount of sodium and increase the amount of potassium) 
lowered SBP by an average 6 mmHg in treated South African 
hypertensive patients from a low socio-economic setting (K 
Charlton, Medical Research Council – personal communication, 
2007). On a population level, the BP-lowering effect of this 
dietary intervention would result in a 20% reduction in the 
number of deaths attributed to high BP, preventing more than 
9 000 deaths in 1 year. In addition, prevention of excessive 
alcohol use and reduction of obesity in the population will 
further reduce BP. 
In addition to the improved lifestyle factors to reduce 
BP, early diagnosis and cost-effective treatment with 
pharmacological agents are also necessary to reduce the disease 
burden associated with raised BP. The use of a multidrug 
regimen including two BP-lowering agents was found to be 
cost-effective for those with elevated absolute risk of CVD 
based on a risk-assessment tool including SBP.22,23  Regardless 
of treatment choice, guidelines defining eligibility for 
medication use must focus on absolute or global clinical risk, in 
which BP is one of many CVD risk factors assessed, instead of 
individual risk factor approaches.22,24  
The linear associations between BP and cholesterol levels as 
well as the degree of obesity and CVD in both developed and 
developing countries5,25 demonstrate the lack of a biological 
justification for the use of cut-off points, such as those that 
define hypertension. The absolute risk approach was also 
found to be more cost-effective in a model of BP control 
management in South Africa26 by both preventing more 
CVD and reducing costs more than guidelines based on just 
treating those with a BP cut-off point of 140/90 mmHg. In 
that analysis it was estimated that the current South African 
clinical guidelines with a cut-off point of 140/90 mmHg cost an 
additional R180 million annually, compared with an approach 
of treating those with a 10-year absolute risk of CVD of 15% or 
greater. Furthermore, the current approach would result in  
5 000 fewer quality-adjusted life years for the adult population 
in 10 years. A similar result was seen in Canada27 when 
comparing the global risk approach with target levels of 
cholesterol for the basis of the treatment decision. In South 
Africa, approximately 2.6 million males and 3.3 million females 
(almost 6 million adults) would be classified as hypertensive 
with the current clinical cut-off point of 140/90 mmHg. A 
re-calculation of the attributable burden using the same RRs 
but a threshold of 140 mmHg, shows that 20% of the deaths 
attributable to high BP result from people with SBP between 
115 mmHg and the clinical cut-off. Further research is needed 
to identify a cost-effective approach to respond to this public 
health problem in our setting.
Conclusion
The data presented here show that poorly managed 
hypertension has a significant impact on the burden of disease 
in South Africa. Despite primary health care guidelines for the 
management of hypertension, data collected in 1998 suggest 
that the condition is poorly diagnosed and inadequately 
treated.6,8 This emphasises the need for improved BP control 
programmes that will simultaneously consider all the CVD 
risk factors in an integrated comprehensive chronic disease 
management programme. In addition, population-based 
strategies to reduce salt and increase potassium intake, limit 
alcohol intake and promote physical activity are needed.  
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